However, less than 50% of breast cancer patients are detected with the elevation of serum CA15–3 and CEA levels, and CA125 is used mainly for detection of ovarian cancer, which is less specific in other cancer types [37, 38]. This evidence concerns the gene CEACAM5 and breast carcinoma.